38% had established osteoporosis, and osteoporotic fractures had occurred in 19%. 12 Almost all these patients were ambulatory at the time of assessment and no difference in the incidence of ...

A single IV dose of the bisphosphonate drug zoledronic acid has been shown to increase bone density at 1 year in women with osteopenia or osteoporosis ... 3 doses), the incidence of new fractures ...

Using data from 638,999 patients, a new study by a research team at the Warren Alpert Medical School found that the incidence ...

The global bone growth products market size was valued at USD 1.29 billion in 2024 and is projected to reach from USD 1.34 billion in 2025 to USD 1.81 billion by 2033, growing at a CAGR of 3.40% ...

The purpose of this review is to describe the available evidence for osteoporosis treatments in young and premenopausal women. A review of articles evaluating the treatment or prevention of ...

Want to bookmark your favourite articles and stories to read or reference later? Start your Independent Premium subscription today. From reproductive rights to climate change to Big Tech, The ...

Holding released a new polygenic risk score report on the genetics of osteoporosis for 23andMe+ Premium members. The report ...

Opens in a new tab or window Intravenous zoledronate (Reclast) administered once every 5 years reduced the incidence of morphometric ... of postmenopausal osteoporosis and every 2 years for ...